{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:38:20Z","timestamp":1784547500062,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["(Contract HHSN266200400084C)"],"award-info":[{"award-number":["(Contract HHSN266200400084C)"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01506","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T14:02:41Z","timestamp":1452002561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor"],"prefix":"10.3389","volume":"6","author":[{"given":"Stephanie","family":"Ascough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K. Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Musson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Les","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Maillere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary J.","family":"Boyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.4049\/jimmunol.0900947","article-title":"Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.","volume":"183","author":"Aagaard","year":"2009","journal-title":"J. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1084\/jem.168.6.2091","article-title":"Mechanisms influencing the immunodominance of T cell determinants.","volume":"168","author":"Adorini","year":"1988a","journal-title":"J. Exp. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/334623a0","article-title":"In vivo competition between self peptides and foreign antigens in T-cell activation.","volume":"334","author":"Adorini","year":"1988b","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect. Immun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1586\/14760584.2015.981533","article-title":"Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design.","volume":"14","author":"Altmann","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1586\/14787210.2015.1032255","article-title":"Anthrax in injecting drug users: the need for increased vigilance in the clinic.","volume":"13","author":"Ascough","year":"2015","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jinf.2013.10.007","article-title":"Injectional anthrax infection due to heroin use induces strong immunological memory.","volume":"68","author":"Ascough","year":"2014a","journal-title":"J. Infect."},{"issue":"e1004085","key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004085","article-title":"Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.","volume":"10","author":"Ascough","year":"2014b","journal-title":"PLoS Pathog."},{"key":"B9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the UK anthrax vaccine.","volume":"42","author":"Baillie","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1016\/j.vaccine.2008.09.010","article-title":"Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.","volume":"26","author":"Baillie","year":"2008","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.32.20877","article-title":"Injectional anthrax - new presentation of an old disease.","volume":"19","author":"Berger","year":"2014","journal-title":"Euro. Surveill."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.molimm.2006.06.014","article-title":"Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes.","volume":"44","author":"Carmicle","year":"2007","journal-title":"Mol. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax.","volume":"341","author":"Dixon","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"e22011","key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022011","article-title":"Subdominant\/Cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.","volume":"6","author":"Dominguez","year":"2011","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s000180050399","article-title":"Anthrax toxins.","volume":"55","author":"Duesbery","year":"1999","journal-title":"Cell Mol. Life. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1073\/pnas.92.5.1779","article-title":"Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen.","volume":"92","author":"Grewal","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.13.20437-en","article-title":"Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000.","volume":"18","author":"Grunow","year":"2013","journal-title":"Euro. Surveill"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes.","volume":"184","author":"Ingram","year":"2010","journal-title":"J. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ni.2513","article-title":"MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells.","volume":"14","author":"Ji","year":"2013","journal-title":"Nat. Immunol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1002\/j.1460-2075.1996.tb01002.x","article-title":"Editing of the HLA-DR-peptide repertoire by HLA-DM.","volume":"15","author":"Kropshofer","year":"1996","journal-title":"EMBO J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2005.05.009","article-title":"The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.","volume":"23","author":"Lazarski","year":"2005","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1128\/IAI.73.10.6547-6551.2005","article-title":"An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.","volume":"73","author":"Lim","year":"2005","journal-title":"Infect. Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis.","volume":"22","author":"Liu","year":"2014","journal-title":"Trends Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/eji.1830100705","article-title":"Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells.","volume":"10","author":"Maizels","year":"1980","journal-title":"Eur. J. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm1202","article-title":"Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.","volume":"11","author":"McMahon","year":"2005","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0167-5699(97)01233-4","article-title":"Modulation of the immunogenicity of antigenic determinants by their flanking residues.","volume":"19","author":"Moudgil","year":"1998","journal-title":"Immunol. Today"},{"key":"B29","doi-asserted-by":"publisher","first-page":"26129","DOI":"10.1074\/jbc.M605482200","article-title":"Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes.","volume":"281","author":"Musson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"52425","DOI":"10.1074\/jbc.M309034200","article-title":"Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis.","volume":"278","author":"Musson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.4049\/jimmunol.175.10.6473","article-title":"DM peptide-editing function leads to immunodominance in CD4 T cell responses in vivo.","volume":"175","author":"Nanda","year":"2005","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.192.6.781","article-title":"DM determines the cryptic and immunodominant fate of T cell epitopes.","volume":"192","author":"Nanda","year":"2000","journal-title":"J. Exp. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1073\/pnas.89.16.7380","article-title":"Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.","volume":"89","author":"Nelson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1128\/IAI.00788-08","article-title":"Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.","volume":"77","author":"Nguyen","year":"2009a","journal-title":"Infect. Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/IAI.00749-09","article-title":"The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.","volume":"77","author":"Nguyen","year":"2009b","journal-title":"Infect. Immun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3201\/eid1808.111343","article-title":"Molecular epidemiologic investigation of an anthrax outbreak among heroin users.","volume":"18","author":"Price","year":"2012","journal-title":"Europe. Emerg. Infect. Dis."},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.02.19465-en","article-title":"An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland.","volume":"15","author":"Ramsay","year":"2010","journal-title":"Euro. Surveill."},{"key":"B38","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: allele variant databases.","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1998.tb01202.x","article-title":"Immune focusing vs diversification and their connection to immune regulation.","volume":"164","author":"Sercarz","year":"1998","journal-title":"Immunol. Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1146\/annurev.iy.11.040193.003501","article-title":"Dominance and crypticity of T cell antigenic determinants.","volume":"11","author":"Sercarz","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1365-3083.2006.01891.x","article-title":"The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T-cell determinant within a native antigen: relevance to disease susceptibility and vaccination.","volume":"65","author":"Sinha","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.4049\/jimmunol.164.6.3177","article-title":"HLA-DR restricted peptide candidates for bee venom immunotherapy.","volume":"164","author":"Texier","year":"2000","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy.","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1073\/pnas.92.6.2214","article-title":"Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity.","volume":"92","author":"Viner","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3201\/eid1510.081717","article-title":"Immunologic response of unvaccinated workers exposed to anthrax.","volume":"15","author":"Wattiau","year":"2009","journal-title":"Belgium. Emerg. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.4049\/jimmunol.181.5.3039","article-title":"Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.","volume":"181","author":"Weaver","year":"2008","journal-title":"J. Immunol."},{"issue":"1009","key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01009","article-title":"Anthrax prophylaxis: recent advances and future directions.","volume":"6","author":"Williamson","year":"2015","journal-title":"Front. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.4049\/jimmunol.1300283","article-title":"Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.","volume":"192","author":"Woodworth","year":"2014","journal-title":"J. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1074\/jbc.M809456200","article-title":"Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells.","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T22:39:21Z","timestamp":1654036761000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01506\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,5]]},"references-count":49,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01506","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,5]]}}}